Catecholamine Synthesis Inhibitors [MoA] - N0000175361

Pharmacologic Class Information

Pharmacologic Code N0000175361
Pharmacologic Name Catecholamine Synthesis Inhibitors
Pharmacologic Uses
  • catecholamine synthesis inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Catecholamine Synthesis Inhibitors

The following table contains 3 products whose active ingredient are classified under the same pharmacologic class Catecholamine Synthesis Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
25010-305Demser Non-Proprietary Name: MetyrosineCapsuleOralBausch Health Us, LlcACTIVE
68682-310Metyrosine Non-Proprietary Name: MetyrosineCapsuleOralOceanside PharmaceuticalsACTIVE
69238-1621Metyrosine Non-Proprietary Name: MetyrosineCapsuleOralAmneal Pharmaceuticals Ny LlcACTIVE